ADA: Combo Injectable Controls Blood Glucose Longer in T2DM
Findings seen for initial injectable therapy with insulin degludec plus liraglutide versus insulin glargine
More Aggressive Statin Tx Needed After Heart Attack in Young Patients
Majority of patients with heart attack <50 years still have high cholesterol one year later
Opioid-Sparing Strategy Still Provides Good Pain Control
Patients surveyed following surgery and only a small 'rescue' opioid Rx postop
Prenatal Antiepileptic Rx Exposure Ups Risk for Behavioral Issues
Findings seen among Dutch children exposed to one of four common antiepileptic drugs in utero
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations
Introduction of infliximab did not lead to drop in hospitalization, intestinal resection, colectomy
Rotavirus Vaccination Tied to Lower Risk for T1DM in Children
No association seen for partial vaccination and incidence of type 1 diabetes
New York State Halts Religious Vaccine Exemption
Those who support the bill say that religion should not trump science
ADA: Teplizumab Can Delay T1DM Progression in Those at Risk
Median time to type 1 diabetes diagnosis 48.4 months with teplizumab and 24.4 months with placebo
Long-Term Opioid Prescribing Up Among Older Cancer Survivors
Cancer survivors diagnosed 2004 to 2008 have higher rates of opioid prescribing versus those diagnosed earlier
Gabapentinoids Linked to Increased Risk for Significant Adverse Outcomes
Risk increased for suicidal behavior, unintentional overdose, road traffic incident, head/body injuries
